Biotech Venture Capital Firms

Founded 2002, invests in disruptive life, physical, and data sciences

Pre-seed firm guaranteeing funds in 10 business days.

Physician-led, immigrant-founded VC targeting healthcare inequities

Early-stage life sciences with 4:59 Initiative model.

Acts as VC and venture studio co-founding startups with 25-30% capital allocation.

Led by active AI practitioners Socher, Manning, Goldbloom.

Invests at concept stage, co-founding breakthrough life sciences platforms.

Technical frontier specialist led by ex-Microsoft strategy executives

Climate-focused agrifood fund with rare food-policy expertise

London-based venture firm focused exclusively on AI-first companies, founded by Nathan Benaich of the State of AI Report.

Focuses exclusively on AI-first companies in technical domains.

Leads mega-rounds for frontier-tech visions with 150+ platform team and media operations.

Seed and early-stage investor emphasizing biotech company creation.

Early-stage venture firm investing in technology and healthcare companies, one of the oldest VC firms in the US.

Deliberate 60/40 tech/healthcare split with transparent partner scoring.

Contrarian n-of-1 investor across frontier sectors.

Analytics-driven co-investor making rapid decisions using proprietary model.

Targets companies applying modern computation to agriculture, mining, and health.

Gets founders priority introductions to deeptech VCs and angel networks.

Early-stage space VC for multi-planetary tech.

Prolific angel investor and author of 'High Growth Handbook,' investing across stages in technology companies.

Venture capital firm affiliated with Fidelity Investments, investing in healthcare and technology companies.

Fidelity-backed formation engine for gene therapy and rare diseases.

Operator-heavy team backing pre-product deep-tech moonshots.

Contrarian, founder-maximalist VC backing hard scientific breakthroughs.

Invests in purpose-driven entrepreneurs reinventing industries.

Google's financially-driven VC with design studio and ML scoring.

CIA-founded venture firm targeting national-security venture-backed startups.

Founded by Eric Schmidt; invests in sensors, ML, and robotics.

Deeptech seed fund investing across chips, chemicals, energy, robotics.

Targets frontier seed and pre-IPO investments.

Early institutional backer sourcing tech from academia and government labs.

Evergreen fund integrated with $10B+ hedge-fund platform.

Serial founder-led with Signal platform and CEO Guild network.

Separate technology and healthcare practices with long-tenured teams.

Healthcare-only platform spanning seed through IPO via public/private arms.

Boston seed investor supporting professional growth.

Deep technology venture fund investing in AI, robotics, and synthetic biology startups with transformative potential.

Early-stage venture firm investing in healthcare and technology companies, with deep expertise in life sciences.

Deep tech venture firm investing in breakthrough scientific startups across energy, transportation, infrastructure, and health.

Crossover healthcare investment firm investing in public and private biotech and pharmaceutical companies.

Invests in very-early to early-stage AI startups with AI research ties.

Solo GP leveraging Google/Netflix/LinkedIn experience to back hard-tech.

MIT-linked venture firm investing in tough tech companies solving the world's biggest problems across energy, health, and computing.

Drug-discovery company creator incubating orphan and rare disease treatments.

Focuses on enabling infrastructure for the space economy.

Healthcare-focused venture arm of Venrock, the Rockefeller family venture fund, investing in biotech and digital health.

Creates companies from in-house discovery labs with big-pharma discipline.

One of Silicon Valley's most influential venture firms, operating as a platform company with deep operational expertise across sectors.

Venture capital firm founded by Peter Thiel investing in revolutionary technology companies that others overlook.

Deep technology venture firm investing in companies at the intersection of science and engineering, from seed through growth.

Leading venture capital firm with dedicated funds for crypto, bio, and AI. Known for their thesis-driven approach and extensive portfolio company support.

A growth equity firm founded by former T. Rowe Price partner Henry Ellenbogen. Focuses on high-quality growth companies with durable competitive advantages across public and private markets.

Venture capital firm investing in agtech, food tech, and biotechnology companies that address global food security and sustainability challenges. They focus on technologies that improve agricultural productivity and food system resilience.

Nashville-based venture capital firm exclusively focused on healthcare technology investments. Deep expertise in digital health, medical devices, and healthcare services technology.

JJDC is the venture capital arm of Johnson & Johnson, investing in breakthrough healthcare innovations across pharmaceuticals, medical devices, and consumer health. They focus on companies developing transformative solutions for patients worldwide.

One of the largest and most active venture capital firms globally with over 45 years of experience. Known for investing across all stages and sectors with particular strength in healthcare and technology.

Chicago-based venture capital firm investing in early-stage healthcare and technology companies. Known for their deep industry expertise and strategic partnerships.

Life sciences venture capital firm investing in biotechnology, pharmaceutical, and medical technology companies. Focuses on translating breakthrough scientific discoveries into transformational medicines and healthcare solutions.

Roche's strategic investment arm focused on early-stage companies developing breakthrough healthcare technologies. Invests in innovative therapeutics, diagnostics, and digital health solutions that align with Roche's strategic priorities.